A CR-UK Phase I Trial of LY3143921
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: a. Colorectal Cancer|b. High Grade Serous Ovarian Cancer|c. Non Small-cell Lung Cancer (Squamous Cell Variant)|d. Squamous Carcinoma of the Oesophagus|e. Squamous Carcinoma of the Head and Neck (HPV Negative)|f. Urothelial Cancer|g. Breast Cancer (Triple Negative Type)|h. Pancreatic Cancer
Interventions: DRUG: LY3143921 hydrate
Sponsor: Cancer Research UK